We assess NRG1’s relevance to schizophrenia in the GWAS era.
The past decade of clinical research on NRG1 and schizophrenia is summarized.
We review preclinical work on NRG1’s role in excitatory/inhibitory neurotransmission.
We propose a strategy forward for future NRG1 research in schizophrenia.